By Yadarisa Shabong Jan 20 (Reuters) - Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV ...

Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's ...

Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

Jan 20 (Reuters) - Japan's Shionogi & Co said on Tuesday it would pay $2.13 billion for new shares in ViiV Healthcare, its ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

Pfizer in ​December had warned that the next few years would be bumpy, ‌beginning with 2026, ‍due to lower sales of its COVID ...

As a result of the acquisition, Pfizer will no longer hold shares of ViiV Healthcare Limited and Shionogi will see its holdings increase to 21.7%. 1 The majority shareholder of ViiV Healthcare Limited ...

GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding: London, UK Wednesday, January 21, 2026, 09:00 Hrs [IST] GSK plc (GSK), and Shionogi & Co., Ltd (Shionogi ...

M+C Saatchi North America is turning to a longtime pharma pro to serve as its inaugural medical advisor. | M+C Saatchi North America is turning to a longtime pharma pro to serve as its inaugural ...

In recent decades, merger and acquisition activity has sent long-standing Michigan businesses' leadership out-of-state and even the country.

By Puyaan Singh and Sneha S K Jan 22 (Reuters) - The Trump administration has rolled back decades-old guidance recommending routine childhood vaccination against influenza and three other infectious ...